Abstract
In this pilot study, the acceptability of approaching 111 newly diagnosed colorectal cancer patients with the offer of genetic testing for hereditary nonpolyposis colorectal cancer (HNPCC) was assessed. A total of 78% of participants found it highly acceptable to have the information about HNPCC brought to their attention at that time.
Original language | English |
---|---|
Pages (from-to) | 1400-1402 |
Journal | British Journal of Cancer |
Volume | 89 |
Issue number | 8 |
DOIs | |
Publication status | Published - 20 Oct 2003 |